Skip to main content
. 2021 Feb 26;118(9):e2021102118. doi: 10.1073/pnas.2021102118

Fig. 2.

Fig. 2.

CDD-1102 is a potent and selective inhibitor of the second bromodomain of BRDT and BRD4. Competitive inhibition of human BET bromodomain (BRDT-BD1, BRDT-BD2, BRD4-BD1, and BRD4-BD2) binding to biotinylated JQ1 by CDD-1102 and (+)−JQ1 using proximity detection assays. GraphPad Prism software was used to generate inhibition fitting curves and to determine IC50 values.